8
Total investments
1
Early stage
5
Mid stage
0
Late stage
6y
Years active
Portfolio
8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Apr 2023
The AI-powered podcast player to help you discover & save highlights from your favorite podcast shows.
Investor
Jan 2022
Hex Trust is a fully-licensed and regulated financial institution for digital assets.
We offer a full suite of custody, staking, trading and investment solutions to builders, investors, and service providers.
We have a global presence with offices in Hong Kong, Singapore, Dubai, Italy, and Vietnam.
Board Observer
Jan 2022
P12 is building the first and only GUI Onchain Engine for onchain games and autonomous worlds. P12 Editor integrates with onchain frameworks like MUD and Dojo, and simplifies gaming development primitives using prefabs and templates. P12 Editor empowers developers to achieve composable games creation, seamless assets deployment and permissionless open economies. P12 raised 8 million USD from investors including Primavera, Galxe, CyberConnect and CCV.
Board Observer
Jul 2021
About YOGO ROBOT
YOGO ROBOT is a Shanghai-based robotics company founded in 2016. As a global leader in intelligent service robots, our core technical team brings together experience from many famous projects to empower the construction of mobile service networks.
Our mission is to create an indoor service robot network for end-users and explore smart, segmented scenarios outside of city roads, adding new vitality to the creation of an organic, digital city.
Contact Us
business@yogorobot.com
Investor
Mar 2021
Noah Medical is building the future of medical robotics. Our next generation robotic platform targets early diagnosis and treatment of patients across multiple indications.
Based in Silicon Valley and backed by well-known institutional investors, our incredibly talented team of 70+ engineers, innovators and industry leaders brings years of experience from the top healthcare companies in the world.
Board Observer
Dec 2020
As the leading AI-based microbiome drug development company in China, Xbiome Co., Ltd. is dedicated to gut microbiome using AI techniques, and committed to the gut health of human being with medical treatments and precise and personalized management.
The gut is the largest microbial ecosystem in the human body. It hosts about 100 trillion microbes – 500 – 1000 unique species, and contains 150-fold more genes than the human genome, which influence the human health systematically. Studies show that more than 50 human diseases are associated with dysbiosis of gut microbiota.
Unlike the traditional paradigm of drug discovery, Xbiomes approach innovatively combines microbial technologies, artificial intelligence, bioinformatics analysis and gut microbiome technologies into a unique drug development platform, which substantially speeds up and improves the success rate of new drug development.
Board Member
Sep 2020
Overview:
AccutarBio employs artificial intelligence to revolutionize drug discovery. With capabilities in side chain flexible mode ligand docking, virtual screening, and drug ADME property prediction, Accutar’s platform beats the industry standard in computation-aided drug design. The company’s hybrid based approach, which uses computational drug design followed by wet lab validation, greatly reduces the time and cost necessary for traditional drug discovery efforts. Accutar is committed to building strong partnerships, and collaborates across academia and the pharmaceutical industry to solve interdisciplinary problems. The company was founded in 2015 and has locations in both Shanghai, China and New York, NY.
Products & Services:
Accutar offers two software packages:
Chemi-Net and Orbital. Chemi-Net is a molecular graph convolutional network for accurate drug property prediction. It was recently shown to improve the accuracy of ADME property prediction by a large margin in comparison to the widely-used methods https://arxiv.org/abs/1803.06236.
Orbital is a deep neural network based docking platform. The prediction accuracy of protein-ligand complex (holo) from ligand free state (apo) structure is significantly higher than current standards. In addition to these tools, AccutarBio offers services in virtual screening for lead discovery; intelligent-SAR for lead optimization and drug property prediction.
Experience · 9 entries
All (9)
Investments (8)
Board (6)
2023
Board Member
Apr 2023
The AI-powered podcast player to help you discover & save highlights from your favorite podcast shows.
2022
Investor
Jan 2022
Hex Trust is a fully-licensed and regulated financial institution for digital assets.
We offer a full suite of custody, staking, trading and investment solutions to builders, investors, and service providers.
We have a global presence with offices in Hong Kong, Singapore, Dubai, Italy, and Vietnam.
Board Observer
Jan 2022
P12 is building the first and only GUI Onchain Engine for onchain games and autonomous worlds. P12 Editor integrates with onchain frameworks like MUD and Dojo, and simplifies gaming development primitives using prefabs and templates. P12 Editor empowers developers to achieve composable games creation, seamless assets deployment and permissionless open economies. P12 raised 8 million USD from investors including Primavera, Galxe, CyberConnect and CCV.
2021
Board Observer
Jul 2021
About YOGO ROBOT
YOGO ROBOT is a Shanghai-based robotics company founded in 2016. As a global leader in intelligent service robots, our core technical team brings together experience from many famous projects to empower the construction of mobile service networks.
Our mission is to create an indoor service robot network for end-users and explore smart, segmented scenarios outside of city roads, adding new vitality to the creation of an organic, digital city.
Contact Us
business@yogorobot.com
Show all 9 entries ↓
Investment activity
2020–2023 · 8 investments
Recent (last 2 years)Earlier
